Logo

List of Chronobiotics



Name SMILES FDA Status Effects Targets Mechanisms Articles
CC1=[N+](C2=CC=CC=C2C(=C1)N)CCCCCCCCCC[N+]3=C(C=C(C4=CC=CC=C43)N)C.[Cl-].[Cl-] Approved CLOCK-BMAL1 Bmal1, BMAL1 expression modulation
CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42 Approved 5-HT7 5-HT7 binding
CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O Approved Histamine 1 receptor Histamine 1 blocker
CC(C)(C)OC(=O)CC1=CC(=C(C=C1CC2=CC(=C(C=C2[125I])OC)OC)OC)OC None MT2 MT2 receptor ligand
ClC=1C=C(C=CC1Cl)N1C(NC2=C(C1=O)C=NN2C2=CC=CC=C2)=O none CCA1 PRR
(B. bifidum W23, B. lactis W51, B. lactis W52) and lactobacilli (L. acidophilus W22, L. casei W56, L. paracasei W20, L. plantarum W62, L. salivarius W24, L. lactis W19) Not approved CLOCK-BMAL1 , Arntl (gene) , NPAS2 , BMAL1 expression (induction) , TIMELESS Core clock modulation, Bmal1, Activation of CLOCK/Bmal1 mediated transcription, Circadian Clock Impact, TIMELESS
C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F Approved mPer1 , CRY1-PER2 complex , CRY1 , CRY1 PER gene exspression modulation, CRY gene expression modulation
CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2 Approved Histamine 1 receptor Histamine 1 blocker
CCC1=NN2C=CC3=C(C2=C1CCNC(=O)C)CCO3 none MT1 MT1 receptor binding, MT2 receptor ligand
C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42 Approved mPer2 , mPer1 , CLOCK-BMAL1 Core clock modulation, Bmal1
C1C2=C(C3=C(C=CC=N3)NC1=O)NC4=C2C=C(C=C4) Br none GSK-3α/β Highly selective, ATP-competitive inhibition of GSK-3 (both α and β isoforms), GSK‑3 Inhibition, Selective GSK-3β Inhibition:, inhibits glycogen synthase kinase-3β (GSK-3β)
CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3 Approved GABAA receptors GABAergic system influence
CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCSC)NC=O Not approved FPR1 , FPR2 FPR2 full agonist, FPR1 full agonist
C1OC2=C(O1)C=C(C=C2)C3=C(NC(=N3)C4=CC=C(C=C4)C(=O)N)C5=CC=CC=N5 none Dec1 gene expression Activation of activin receptor-like kinase (ALK), by an immediate-early induction of Dec1
CC1=NC=C(N1CCO)[N+](=O)[O-] None Microbiota Melatonin synthesis alteration
C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O Approved Lanosterol 14-α-demethylase (fungal CYP51) Inhibits the fungal enzyme lanosterol 14-α-demethylase (CYP51)
CCCC(=O)NCCC1=C2C3=CC=CC=C3CCCN2C4=C1C=C(C=C4)OC none Melatonin receptor , MT1 , MT2 MT1 antagonist, Melatonin receptor binding, antagonist of melatonin receptors, MT2 receptor antagonist, MT1 receptor binding, MT2 receptor ligand
[2H]C([2H])(C1=CNC2=C1C=C(C=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)OC)OC(=O)C)OC(=O)C)OC(=O)C)C([2H])([2H])NC(=O)C Not approved MT1 , MT2 Melatonin receptor binding
C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4 Approved GABAA receptors GABAergic system influence
C1=CC=C(C(=C1)C(=O)O)O none Unknown | Multiple plant targets Plastoquinone interaction
CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O Approved Unknown Central clock rescue via microbial community alteration
CC1=C(C=C(N1CCCN2CCOCC2)C3=CC=CC=C3)C(=O)NC4=CC=CC(=C4)C(F)(F)F Not approved TRPV4 Channel This inhibition of TRPV4-mediated signaling can affect downstream pathways involved in the regulation of the circadian clock.
CCC(C)C1(C(=O)NC(=O)NC1=O)CC Approved GABAA receptors GABAergic system influence
C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O Approved REV-ERBα Core clock suppression
CC(C)(C[C@H]1CN(C2=C(O1)C=CC(=C2)C3=CC(=CC(=C3)F)OC(F)F)S(=O)(=O)C4=CC=CC(=C4)C(F)(F)F)C(=O)O Not approved RORB , ROR gamma ROR, RORγ binding